Tag Archives: STALICLA

Stalicla Signs Exclusive In Licensing Agreement For Late Stage Clinical Neuropsychiatric And Neurodevelopmental Disorder Treatment

BIOTECH

STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment
January 9, 2023

STALICLA signs exclusive in-licensing agreement for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines...

Stalicla Sa And Evgen Pharma Plc Ink $160.5m Licensingdeal For Sfx 01

BIOTECH

Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
October 12, 2022

Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders...

This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept